Herantis Pharma Oyj (HRTIS) — Cash Flow Quality Index
Herantis Pharma Oyj (HRTIS) has a Cash Flow Quality Index of -1.41x as of December 2023. Operating cash flow of €-2.92 Million is below net income of €2.08 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore HRTIS strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Herantis Pharma Oyj Cash Flow Quality Index (2023–2023)
Historical Cash Flow Quality Index for Herantis Pharma Oyj across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Herantis Pharma Oyj tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Herantis Pharma Oyj (2023–2023)
Year-by-year earnings quality comparison for Herantis Pharma Oyj. For live market cap and the full company financial profile, see market cap of Herantis Pharma Oyj.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -16.57x | €-4.64 Million | €279.84K | — |